{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:16:15Z","timestamp":1791893775348,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RF201912370112"],"award-info":[{"award-number":["RF201912370112"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC2023-RC2024-RC2025"],"award-info":[{"award-number":["RC2023-RC2024-RC2025"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017026","name":"Spastic Paraplegia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phrs.2025.107836","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:01:26Z","timestamp":1750503686000},"page":"107836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3910-6836","authenticated-orcid":false,"given":"Chiara","family":"Vantaggiato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Guarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Brivio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Panzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Speltoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sentiljana","family":"Gumeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genny","family":"Orso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2025.107836_bib1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","article-title":"Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome","volume":"82","author":"Hanein","year":"2008","journal-title":"Am. J. Hum. Genet"},{"issue":"Pt3","key":"10.1016\/j.phrs.2025.107836_bib2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awm293","article-title":"Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration","volume":"131","author":"Stevanin","year":"2008","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib3","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/jnnp.2008.167528","article-title":"Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia","volume":"80","author":"Sch\u00fcle","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 7","key":"10.1016\/j.phrs.2025.107836_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awu121","article-title":"Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48","volume":"137","author":"Pensato","year":"2014","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.phrs.2025.107836_bib5","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1091\/mbc.e13-03-0170","article-title":"Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15","volume":"24","author":"Hirst","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000408","article-title":"A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia","volume":"8","author":"S\u0142abicki","year":"2010","journal-title":"PLoS Biol."},{"issue":"7300","key":"10.1016\/j.phrs.2025.107836_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nature09076","article-title":"Termination of autophagy and reformation of lysosomes regulated by mTOR","volume":"465","author":"Yu","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2025.107836_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yexcr.2012.09.004","article-title":"Autophagic lysosome reformation","volume":"319","author":"Chen","year":"2013","journal-title":"Exp. Cell Res"},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib9","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1172\/JCI77598","article-title":"Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation","volume":"124","author":"Chang","year":"2014","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.phrs.2025.107836_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005454","article-title":"In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11","volume":"11","author":"Varga","year":"2015","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acn3.64","article-title":"Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11","volume":"1","author":"Renvois\u00e9","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107836_bib12","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1080\/15548627.2021.1891848","article-title":"Mouse models for hereditary spastic paraplegia uncover a role of PI4K2A in autophagic lysosome reformation","volume":"17","author":"Khundadze","year":"2021","journal-title":"Autophagy"},{"issue":"Pt10","key":"10.1016\/j.phrs.2025.107836_bib13","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/brain\/awt227","article-title":"Defective autophagy in spastizin mutated patients with hereditary spastic paraparesis type 15","volume":"136","author":"Vantaggiato","year":"2013","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.phrs.2025.107836_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/auto.27173","article-title":"ZFYVE26\/SPASTIZIN: a close link between complicated hereditary spastic paraparesis and autophagy","volume":"10","author":"Vantaggiato","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15548627.2018.1507438","article-title":"ZFYVE26\/SPASTIZIN and SPG11\/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis","volume":"15","author":"Vantaggiato","year":"2019","journal-title":"Autophagy"},{"issue":"16","key":"10.1016\/j.phrs.2025.107836_bib16","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/hmg\/ddac063","article-title":"SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction","volume":"31","author":"Marrone","year":"2022","journal-title":"Hum. Mol. Genet"},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003988","article-title":"A hereditary spastic paraplegia mouse model supports a role of ZFYVE26\/SPASTIZIN for the endolysosomal system","volume":"9","author":"Khundadze","year":"2013","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.phrs.2025.107836_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005454","article-title":"In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11","volume":"11","author":"Varga","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.phrs.2025.107836_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s42003-019-0615-z","article-title":"Loss of spatacsin impairs cholesterol trafficking and calcium homeostasis","volume":"2","author":"Boutry","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.phrs.2025.107836_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","article-title":"Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration","volume":"102","author":"Branchu","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/ddy397","article-title":"Human SPG11 cerebral organoids reveal cortical neurogenesis impairment","volume":"28","author":"P\u00e9rez-Brangul\u00ed","year":"2019","journal-title":"Hum. Mol. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.24633","article-title":"GSK3\u00df-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model","volume":"79","author":"Mishra","year":"2016","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.phrs.2025.107836_bib23","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of lysosome membrane recycling causes accumulation of gangliosides that contribute to neurodegeneration","volume":"23","author":"Boutry","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107836_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fnins.2018.00914","article-title":"Tideglusib rescues neurite pathology of SPG11 iPSC derived cortical neurons","volume":"12","author":"Pozner","year":"2018","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13023-018-0844-0","article-title":"Miglustat in niemann-pick disease type C patients: a review","volume":"13","author":"Pineda","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107836_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/brain\/awac308","article-title":"Rescue of lysosomal function as therapeutic strategy for SPG15 hereditary spastic paraplegia","volume":"146","author":"Vantaggiato","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","article-title":"Small molecules enhance autophagy and reduce toxicity in Huntington's disease models","volume":"3","author":"Sarkar","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib29","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41467-022-31905-0","article-title":"Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance","volume":"13","author":"Wrobel","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib30","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1096\/fj.10-175158","article-title":"A small-molecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway","volume":"25","author":"Tian","year":"2011","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11064-018-2652-2","article-title":"SMER28 attenuates dopaminergic toxicity mediated by 6-hydroxydopamine in the rats via modulating oxidative burdens and autophagy-related parameters","volume":"43","author":"Darabi","year":"2018","journal-title":"Neurochem. Res"},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10637-018-0566-0","article-title":"SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy","volume":"36","author":"Koukourakis","year":"2018","journal-title":"Invest N. Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"16","key":"10.1016\/j.phrs.2025.107836_bib34","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.3390\/ijms22168975","article-title":"Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3\u03b2 as a drug candidate for the treatment of amyotrophic lateral sclerosis","volume":"22","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ph12010011","article-title":"The therapeutic potential of naringenin: a review of clinical trials","volume":"12","author":"Salehi","year":"2019","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dom.13868","article-title":"Safety and pharmacokinetics of naringenin: A randomized, controlled, single-ascending-dose clinical trial","volume":"22","author":"Rebello","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2025.107836_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.660714","article-title":"Hereditary spastic paraplegia and future therapeutic directions: beneficial effects of small compounds acting on cellular stress","volume":"15","author":"Gumeni","year":"2021","journal-title":"Front Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2025.107836_bib38","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ncb3407","article-title":"Protein kinase C controls lysosome biogenesis independently of mTORC1","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"6036","key":"10.1016\/j.phrs.2025.107836_bib39","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.phrs.2025.107836_bib40","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum. Mol. Genet"},{"issue":"2","key":"10.1016\/j.phrs.2025.107836_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10571-017-0519-8","article-title":"Protective Role Of Naringenin Against A\u03b225-35-Caused Damage via ER and PI3K\/Akt-Mediated Pathways","volume":"38","author":"Zhang","year":"2018","journal-title":"Cell Mol. Neurobiol."},{"issue":"PtA","key":"10.1016\/j.phrs.2025.107836_bib42","article-title":"The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K\/AKT pathway after hypoxic-ischemic brain damage","volume":"318","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14415","article-title":"Naringenin: a prospective therapeutic agent for Alzheimer's and Parkinson's disease","volume":"46","author":"Goyal","year":"2022","journal-title":"J. Food Biochem"},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/14756366.2022.2041627","article-title":"Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease","volume":"37","author":"Yang","year":"2022","journal-title":"J. Enzym. Inhib. Med Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib45","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1038\/s41598-017-04974-1","article-title":"Naringenin impairs two-pore channel 2 activity and inhibits vegf-induced angiogenesis","volume":"7","author":"Pafumi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107836_bib46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bcp.2013.03.018","article-title":"The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia\/reperfusion injury","volume":"85","author":"Testai","year":"2013","journal-title":"Biochem. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2025.107836_bib47","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.4049\/jimmunol.1602016","article-title":"Naringenin ameliorates acute inflammation by regulating intracellular cytokine degradation","volume":"199","author":"Jin","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41421-021-00363-1","article-title":"Targeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm","volume":"8","author":"Jia","year":"2022","journal-title":"Cell Discov."},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/auto.4451","article-title":"Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3","volume":"3","author":"Kimura","year":"2007","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135124","article-title":"Defective lysosome reformation during autophagy causes skeletal muscle disease","volume":"131","author":"McGrath","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107836_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-59745-516-9_13","article-title":"GAL4\/UAS targeted gene expression for studying Drosophila Hedgehog signaling","volume":"397","author":"Busson","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/cells11010129","article-title":"Drosophila D-idua reduction mimics mucopolysaccharidosis type i disease-related phenotypes","volume":"11","author":"De Filippis","year":"2021","journal-title":"Cells"},{"issue":"5\u20136","key":"10.1016\/j.phrs.2025.107836_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000445435","article-title":"Human senataxin modulates structural plasticity of the neuromuscular junction in drosophila through a neuronally conserved TGF\u03b2 signalling pathway","volume":"16","author":"Mushtaq","year":"2016","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib54","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1038\/s41467-023-38421-9","article-title":"Drosophila motor neuron boutons remodel through membrane blebbing coupled with muscle contraction","volume":"14","author":"Fernandes","year":"2023","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.phrs.2025.107836_bib55","doi-asserted-by":"crossref","first-page":"13843","DOI":"10.1074\/jbc.M808515200","article-title":"Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission","volume":"284","author":"Dagda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107836_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneumeth.2016.01.008","article-title":"Quantification of mitochondrial morphology in neurites of dopaminergic neurones using multiple parameters","volume":"262","author":"Wiemerslage","year":"2016","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.phrs.2025.107836_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","article-title":"A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture","volume":"119","author":"Valente","year":"2017","journal-title":"Acta. Histochem."},{"key":"10.1016\/j.phrs.2025.107836_bib58","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3389\/fnins.2019.01202","article-title":"Naringenin ameliorates drosophila reepa hereditary spastic paraplegia-linked phenotypes","volume":"13","author":"Napoli","year":"2019","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib59","article-title":"Orso, Flavonoids regulate lipid droplets biogenesis in drosophila melanogaster","volume":"14","author":"Fantin","year":"2019","journal-title":"Nat. Prod. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1083\/jcb.201009067","article-title":"p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding","volume":"192","author":"Itakura","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107836_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.793328","article-title":"Selective autophagy receptor p62\/SQSTM1, a pivotal player in stress and aging","volume":"10","author":"Kumar","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.phrs.2025.107836_bib62","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1172\/JCI24694","article-title":"Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine","volume":"115","author":"Orso","year":"2005","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddv632","article-title":"Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms","volume":"25","author":"Julien","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib64","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ajhg.2016.04.002","article-title":"Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia","volume":"98","author":"Gan-Or","year":"2016","journal-title":"Am. J. Hum. Genet"},{"issue":"6","key":"10.1016\/j.phrs.2025.107836_bib65","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202102001","article-title":"Lysosome biogenesis: Regulation and functions","volume":"220","author":"Yang","year":"2021","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107836_bib66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cub.2005.01.049","article-title":"Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells","volume":"15","author":"Bright","year":"2005","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107836_bib67","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.149.5.1053","article-title":"The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles","volume":"149","author":"Pryor","year":"2000","journal-title":"J. Cell Biol."},{"issue":"309","key":"10.1016\/j.phrs.2025.107836_bib68","doi-asserted-by":"crossref","first-page":"ra9","DOI":"10.1126\/scisignal.2004754","article-title":"The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris","volume":"7","author":"Martina","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1016\/j.phrs.2025.107836_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105255","article-title":"Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro","volume":"163","author":"Clementi","year":"2021","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.107836_bib70","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fphar.2020.00364","article-title":"Pharmacokinetics and metabolism of naringin and active metabolite naringenin in rats, dogs, humans, and the differences between species","volume":"11","author":"Bai","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107836_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105264","article-title":"Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review","volume":"171","author":"Memariani","year":"2021","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.phrs.2025.107836_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.825","article-title":"The therapeutic effects of naringenin on bronchial pneumonia in children","volume":"9","author":"Yao","year":"2021","journal-title":"Pharm. Res Perspect."},{"issue":"1","key":"10.1016\/j.phrs.2025.107836_bib73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s13063-021-05784-7","article-title":"Effects of naringenin supplementation in overweight\/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial","volume":"22","author":"Naeini","year":"2021","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.phrs.2025.107836_bib74","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int J. Clin. Pr."},{"issue":"12","key":"10.1016\/j.phrs.2025.107836_bib75","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4155\/tde-2023-0086","article-title":"A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug- delivery formulations","volume":"14","author":"Ganesh","year":"2023","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.phrs.2025.107836_bib76","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/brain\/awac379","article-title":"Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial","volume":"146","author":"Schiffmann","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2025.107836_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106564","article-title":"Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice","volume":"199","author":"Fortier","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2025.107836_bib78","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s12325-024-02881-2","article-title":"Qualitative study of the patient experience with venglustat for gaucher disease type 3 in a phase 2 open-label, multicenter, multinational study (LEAP)","volume":"41","author":"Schiffmann","year":"2024","journal-title":"Adv. Ther."},{"issue":"18","key":"10.1016\/j.phrs.2025.107836_bib79","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1021\/acs.jmedchem.2c01050","article-title":"Venglustat inhibits protein N-terminal methyltransferase 1 in a substrate-competitive manner","volume":"65","author":"Dong","year":"2022","journal-title":"J. Med Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:24:03Z","timestamp":1777605843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":79,"alternative-id":["S1043661825002610"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107836","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringenin and SMER28 target lysosomal reformation and rescue SPG11 and SPG15 hereditary spastic paraplegia phenotypes","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107836"}}